OBJECTIVES: To determine the rates of venous thromboembolism (VTE) during admission and within 30 days of hospital discharge in inflammatory bowel (IBD) patients undergoing colonic resection using the ACS National Surgical Quality Improvement Project (NSQIP) database and to compare these rates to VTE rates in cohorts of patients undergoing colonic resection for several other colonic pathologies. BACKGROUND: High rates of VTE have been demonstrated in hospitalized IBD patients. However, rates of postdischarge VTE in IBD patients are understudied. METHODS: Demographic, operative, and outcomes data for 96,999 patients undergoing colonic resection for diverticulitis, colorectal cancer (CRC), benign neoplasms, ulcerative colitis (UC), and Crohn's disease (CD) between 2005 and 2011 was obtained. Student t and χ tests were used for univariate analysis. A logistic multivariate analysis was performed with all significant variables. Propensity score matching was utilized to compare the VTE incidences between the groups. RESULTS: Highest VTE risk was seen in obese patients [odds ratio (OR) = 1.41], those older than 73 years (OR = 1.58) and with bleeding disorders (OR = 1.44), American Society of Anesthesiology class III/IV (OR = 1.52/1.86), preoperative systemic inflammatory response syndrome (OR = 1.55), sepsis (OR = 1.48) or steroid use (OR = 1.63), and primary diagnosis of UC (OR = 2.10). The UC group had the highest incidence of VTE (2.74%), followed by CRC patients (1.74%). A 1.2% incidence was seen in the CD population, and 41.5% of the UC-VTEs were diagnosed after discharge. CONCLUSIONS: This study affirms that inpatient UC patients undergoing colonic resection are at high risk for VTE and suggests that this risk persists into the postdischarge period. Thus, these patients should be given appropriate prophylaxis.
OBJECTIVES: To determine the rates of venous thromboembolism (VTE) during admission and within 30 days of hospital discharge in inflammatory bowel (IBD) patients undergoing colonic resection using the ACS National Surgical Quality Improvement Project (NSQIP) database and to compare these rates to VTE rates in cohorts of patients undergoing colonic resection for several other colonic pathologies. BACKGROUND: High rates of VTE have been demonstrated in hospitalized IBDpatients. However, rates of postdischarge VTE in IBDpatients are understudied. METHODS: Demographic, operative, and outcomes data for 96,999 patients undergoing colonic resection for diverticulitis, colorectal cancer (CRC), benign neoplasms, ulcerative colitis (UC), and Crohn's disease (CD) between 2005 and 2011 was obtained. Student t and χ tests were used for univariate analysis. A logistic multivariate analysis was performed with all significant variables. Propensity score matching was utilized to compare the VTE incidences between the groups. RESULTS: Highest VTE risk was seen in obesepatients [odds ratio (OR) = 1.41], those older than 73 years (OR = 1.58) and with bleeding disorders (OR = 1.44), American Society of Anesthesiology class III/IV (OR = 1.52/1.86), preoperative systemic inflammatory response syndrome (OR = 1.55), sepsis (OR = 1.48) or steroid use (OR = 1.63), and primary diagnosis of UC (OR = 2.10). The UC group had the highest incidence of VTE (2.74%), followed by CRCpatients (1.74%). A 1.2% incidence was seen in the CD population, and 41.5% of the UC-VTEs were diagnosed after discharge. CONCLUSIONS: This study affirms that inpatient UC patients undergoing colonic resection are at high risk for VTE and suggests that this risk persists into the postdischarge period. Thus, these patients should be given appropriate prophylaxis.
Authors: Zhobin Moghadamyeghaneh; Reza Fazl Alizadeh; Mark H Hanna; Grace Hwang; Joseph C Carmichael; Steven Mills; Alessio Pigazzi; Michael J Stamos Journal: World J Surg Date: 2016-05 Impact factor: 3.352
Authors: Nicholas J Skertich; Justin Gerard; Jennifer Poirier; Martin Hertl; Sam G Pappas; Erik Schadde; Xavier M Keutgen Journal: J Gastrointest Surg Date: 2019-01-22 Impact factor: 3.452
Authors: Bharati Kochar; Edward L Barnes; Anne F Peery; Katherine S Cools; Joseph Galanko; Mark Koruda; Hans H Herfarth Journal: Inflamm Bowel Dis Date: 2018-07-12 Impact factor: 5.325
Authors: Anudeep Mukkamala; John R Montgomery; Ana C De Roo; James W Ogilvie; Scott E Regenbogen Journal: Dis Colon Rectum Date: 2020-07 Impact factor: 4.412
Authors: Cary Jo R Schlick; Tarik K Yuce; Anthony D Yang; Michael F McGee; David J Bentrem; Karl Y Bilimoria; Ryan P Merkow Journal: Surgery Date: 2020-10-17 Impact factor: 3.982